GB1127405A - Pharmaceutical composition for the treatment of parkinson syndrome - Google Patents

Pharmaceutical composition for the treatment of parkinson syndrome

Info

Publication number
GB1127405A
GB1127405A GB4047065A GB4047065A GB1127405A GB 1127405 A GB1127405 A GB 1127405A GB 4047065 A GB4047065 A GB 4047065A GB 4047065 A GB4047065 A GB 4047065A GB 1127405 A GB1127405 A GB 1127405A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
treatment
unbranched
sept
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4047065A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siegfried AG
Original Assignee
Siegfried AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried AG filed Critical Siegfried AG
Publication of GB1127405A publication Critical patent/GB1127405A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1,127,405. Pharmaceutical compositions. SIEGFRIED A.G. 22 Sept., 1965 [22 Sept., .1964], No. 40470/65. Heading A5B. A pharmaceutical composition for treating Parkinson's disease comprises a N,N-diphenylcarbamate or acid addition salt thereof, where R is C 1-4 alkyl, R, and R 2 are each H or C 1-4 alkyl, and A is a branched or unbranched C 1-4 alkylene chain, and a carbamate of the formula where R 3 represents H or halogen, and B is a branched or unbranched C 1-4 alkylene chain, optionally containing a halogen substituent together with a carrier. The composition is preferably administered orally in conventional dosage unit forms e.g. capsules and tablets.
GB4047065A 1964-09-22 1965-09-22 Pharmaceutical composition for the treatment of parkinson syndrome Expired GB1127405A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39840964A 1964-09-22 1964-09-22

Publications (1)

Publication Number Publication Date
GB1127405A true GB1127405A (en) 1968-09-18

Family

ID=23575284

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4047065A Expired GB1127405A (en) 1964-09-22 1965-09-22 Pharmaceutical composition for the treatment of parkinson syndrome

Country Status (1)

Country Link
GB (1) GB1127405A (en)

Similar Documents

Publication Publication Date Title
OA09023A (en) Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams.
FR2361901A1 (en) NUCLEOTIDES SUBSTITUTION DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
GB1388358A (en) Taste-improving formulations of oral penicillins
GB1174051A (en) Aminophenol Derivatives and Analgesic and Antipyretic Compositions
GB1362845A (en) Benzyl alcohol derivatives
GB1127405A (en) Pharmaceutical composition for the treatment of parkinson syndrome
GB1126153A (en) Novel polygalacturonic acid derivative
ES376688A1 (en) Benzdiazepine derivatives
GB1351437A (en) N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity
GB1500300A (en) Pharmaceutical preparation for the treatment of circulatory disorders
GB1215152A (en) Biguanide derivatives and pharmaceutical preparations containing them
GB1354734A (en) Pharmaceutical compositions comprising aminoguanidine derivatives
GB1136918A (en) Propanolamine derivatives
GB1352392A (en) Phenylisopropylamine derivatives
GB1464082A (en) Pharmaceutical 'ompositions containing benzylamines
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
FR2356652A1 (en) NEW PENICILLINS AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
GB1132397A (en) Improvements in or relating to fluorene derivatives and the manufacture thereof
IE34313L (en) 2-hydroxy-5-aminobenzamides
GB1276942A (en) Derivatives of chloramphenicol and thiamphenicol
GB1279380A (en) Improvements in or relating to hydantoins and compositions thereof
GB1316333A (en) Pyrimidyl-ureas their preparation and use as immunosuppresants and anti-viral agents
GB1342643A (en) Thioacetanilide derivatives
GB1395929A (en) Thioureas
GB1280244A (en) Serum triglyceride-lowering compositions